ProHance® (Gadoteridol) Injection, 279.3 mg/mL is one of the most stable macrocyclic gadolinium-based contrast agents (GBCAs), with a molecular structure that “cages” gadolinium inside.1,2 Out of 9 GBCAs in the marketplace, ProHance is the only agent approved for a cumulative dose of 0.3 mmol/kg.1
ProHance (Gadoteridol) Injection, 279.3 mg/mL provides macrocyclic GBCA stability, along with proven efficacy. The TRUTH study showed no significant difference in detection and characterization of central nervous system (CNS) lesions with ProHance® (Gadoteridol) when compared to Gadavist®. In addition, no difference was found by any reader for any of the 5 qualitative image evaluation endpoints:3
ProHance provided improved delineation and enhancement of primary and secondary neoplastic lesions of the brain and spine in children.4 In a multicenter clinical trial of 103 children, 60% of scans were enhanced, and 30-95% of scans resulted in additional diagnostic information.1
Ensure your medical imaging procedures are supported by a reliable supply of essential contrast media. Spectrum Medical Imaging Co. is your trusted partner for high-quality medical imaging services and products, including BRACCO PROHANCE 17ML PFS 5/BOX, designed to enhance diagnostic confidence in Magnetic resonance imaging (MRI).
The BRACCO PROHANCE 17ML PFS (Pre-filled Syringe) 5/BOX provides advanced convenience and precision for healthcare providers performing intravenous injections during medical imaging procedures.
Designed to streamline workflow and ensure optimal diagnostic outcomes, ProHance plays a critical role in modern magnetic resonance imaging (MRI).
ProHance continues to be a reliable solution for facilities aiming to uphold high standards of clinical excellence and deliver clear, confident diagnostic results across varied patient populations.
At Spectrum Medical Imaging Co., we recognize that selecting the right gadolinium-based contrast agent is essential for achieving diagnostic excellence in medical imaging.
ProHance, developed by Bracco Imaging, is a trusted choice among radiologists and healthcare professionals due to its consistent performance, strong safety profile, and streamlined use in medical imaging services.
Supporting advanced diagnostic protocols across multiple specialties, ProHance enables facilities to uphold superior clinical standards, enhancing both imaging workflows and patient care outcomes.
At Spectrum Medical Imaging Co., we supply ProHance to empower healthcare facilities to deliver consistently high-quality imaging results. ProHance facilitates the creation of detailed MRI scans with vivid enhancement, aiding in the precise visualization of lesion borders, internal tissue morphology, and disease extent.
Its superior imaging characteristics promote focal contrast uptake and exceptional visualization of blood vessels, critical for diagnosing cardiovascular diseases and neurological disorders. With ProHance, healthcare providers gain greater confidence when interpreting complex medical conditions, leading to faster, more accurate diagnoses.
At Spectrum Medical Imaging Co., we prioritize patient safety when recommending contrast agents for medical imaging services. ProHance (Gadoteridol), a macrocyclic gadolinium-based contrast media agent, is valued for its outstanding stability and low gadolinium retention properties.
It is considered a safe and effective option for a wide range of patients, including pediatric patients and individuals with compromised renal function, following careful clinical evaluation. Designed to minimize adverse reactions, ProHance supports safer magnetic resonance imaging outcomes for high-risk patients, ensuring healthcare providers can deliver optimal care even in complex imaging scenarios.
Partnering with Spectrum Medical Imaging Co. for your BRACCO PROHANCE 17ML PFS 5/BOX needs means collaborating with a recognized leader in medical imaging services and a trusted contrast media supplier. Our commitment to excellence supports healthcare facilities across all aspects of diagnostic care.
Choosing Spectrum Medical Imaging Co. means having a dedicated partner committed to excellence in contrast media in radiology, magnetic resonance imaging, and full-spectrum medical imaging services. We help your facility focus on delivering world-class care with trusted products, seamless service, and total peace of mind.
Ensure your imaging department is supported by a trusted contrast media supplier committed to clinical excellence and operational efficiency. At Spectrum Medical Imaging Co., we not only provide dependable access to essential products like BRACCO PROHANCE 17ML PFS 5/BOX, but we also deliver comprehensive services, including expert contrast injector repair and maintenance, to keep your facility running smoothly.
Enhance your medical imaging services with the industry’s most trusted solutions. Contact Spectrum Medical Imaging Co. today for a personalized consultation, competitive pricing, and fast, reliable supply tailored to your facility’s needs.
BRACCO PROHANCE 17ML PFS 5/BOX is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to enhance the visibility of certain tissues, structures, and lesions, particularly in the CNS, soft tissues, and vascular system.
The pre-filled syringe format (PFS) offers convenience, reduces preparation time, and helps ensure accurate dosing, contributing to improved workflow efficiency in imaging departments.
ProHance has a macrocyclic structure and low retention properties. However, the suitability of any gadolinium-based contrast agent for patients with renal impairment should be determined by a healthcare professional based on individual patient assessment and current guidelines.
Spectrum Medical Imaging Co. offers fast nationwide shipping, with orders typically processed and shipped within 24-48 hours.
